WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001087038) $g(b)-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/087038    International Application No.:    PCT/US2001/014357
Publication Date: 22.11.2001 International Filing Date: 03.05.2001
Chapter 2 Demand Filed:    07.12.2001    
IPC:
C07D 471/04 (2006.01), C07D 495/04 (2006.01)
Applicants: ORTHO-MCNEIL PHARMACEUTICAL, INC. [US/US]; U.S. Route 202 Raritan, NJ 08869 (US)
Inventors: SUI, Zhihua; (US).
MACIELAG, Mark, J.; (US)
Agent: JOHNSON, Philip, S.; Johnson & Johnson One Johnson & Johnson Plaza New Brunswick, NJ 08933 (US).
APPOLINA, Mary, A.; Johnson & Johnson One Johnson & Johnson Plaza New Bruswick, NJ 08933 (US)
Priority Data:
60/204,667 17.05.2000 US
Title (EN) $g(b)-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
(FR) DERIVES $G(B)-CARBOLINE UTILES EN TANT QU'INHIBITEURS DE LA PHOSPHODIESTERASE
Abstract: front page image
(EN)The present invention relates to novel $g(b)-carboline derivatives of the general formula (I), wherein all the variables are as described within the specification, useful as phosphodiesterase inhibitors. The present invention further relates to use of the described derivatives for the treatment of diseases and conditions related to PDE, for example male erectile dysfunction.
(FR)La présente invention se rapporte à de nouveaux dérivés $g(b)-carboline représentés par la formule générale (I), dans laquelle toutes les variables sont décrites dans la description associée; ces dérivés s'avèrent utiles en tant qu'inhibiteurs de la phosphodiestérase. La présente invention se rapporte également à l'utilisation de ces dérivés pour le traitement de maladies et d'affections associées à la phosphodiestérase, telles que par exemple la dysérection.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)